Free tool
Diagnostics stocks
We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $57.34M. Across the group, the median move over the past trading day is +0.24%. Price change over the past year runs from −88.4% to +46.2% across the middle 80 percent of the group, with a median of −55.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% | Oct 28, 2026 |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% | Nov 3, 2026 |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% | Nov 16, 2026 |
| MDXH | MDxHealth SA | $72.15M | Micro cap | −84.51% | Nov 12, 2026 |
| PAVM | PAVmed Inc. | $42.54M | Micro cap | −63.21% | Nov 12, 2026 |
| CODX | Co-Diagnostics, Inc. | $8.73M | Micro cap | −87.22% | Nov 16, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.71M | Micro cap | −48.46% | Nov 6, 2026 |
| REVB | Revelation Biosciences, Inc. | $3.80M | Micro cap | −91.25% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.